Amy's story
Facing a superbug at just 19 years old
Surviving a life-threatening infection against the odds
In 2011, Russell was travelling in India when a serious electric shock in a hotel shower left him with a life threatening superbug – NDM-1.
Antimicrobial resistance happens when microbes - including bacteria, fungi, viruses and parasites - evolve to resist the drugs designed to kill them – antibiotics, antifungals, antivirals and antiparasitics. Today these microbes are often described as ‘superbugs’.
My sister asked my friends on Facebook to pray for me
“My experience with drug-resistance dates back to the spring of 2011, when I became the victim of an unfortunate incident in the shower of a hotel room in Bodh-Gaya, in Northern India, where I received a massive electric shock.
Prior to my shocking incident, I had spent months on the beach, eating well and swimming every day, and passed several weeks in meditation halls. Physically and mentally, I was in the best possible condition to cope with the trauma that was coming my way.
Six months previously, The Lancet had published an article about a new superbug, New Delhi metallo-beta-lactamase-1 (NDM-1). NDM-1 is a mutant enzyme that makes bacteria extremely hard to kill with antibiotics.
The Lancet discussed three varieties of NDM-1. When I was screened at hospital in Bristol, they discovered I had five varieties - including cholera. I was carrying an antibiotic-resistant strain of cholera.
Happily, the microbiologists were alert to the problem and the infection control procedures were extremely thorough. Otherwise, I might now be as famous as Typhoid Mary!
As it transpired, I did make UK medical history, but anonymously. The Lancet referred to me as, 'an otherwise healthy 49 year-old man'.”
Your support can help fund life-changing medical research into neglected health conditions – and bring us closer to a fairer, healthier future for every mind and every body
Support usNew Delhi metallo-beta-lactamase-1 (NDM-1) is not a virus or a bacteria itself, but a specific gene that makes bacteria highly resistant to almost all powerful antibiotics .
When a bacterium carries this gene, it creates a special enzyme that resists medicines.
Common bacteria (like E. coli) can pick up the NDM-1 gene, and once they do, standard infections suddenly become incredibly difficult, and sometimes impossible, to treat.
While I had been elsewhere, my body had been a battle ground.
“After being kept in coma for about three weeks, I recovered in total isolation.
The room I was in was intended to house several more beds. Visitors had to change into surgical scrubs before meeting me and, after leaving my room, shower before dressing in their own clothes and directly leaving the building.
This is the environment in which I recovered and discovered what had happened while I had been sleeping.
While I had been elsewhere, my body had been a battle ground.
One of the first things I discovered was that my left hand had been amputated - replaced by a swollen meaty club of pain. No more manual work for me!
My reconstructed left foot was swathed in a vacuum dressing that sucked the air out to promote adhesion of the skin transplanted from my thigh. I5 years later, my stump is still painful and I still have a tide mark above the knee of my left leg.
When the clinicians started telling me about ‘hard-to-kill gram-negative microorganisms’, that seemed like the least of my worries. It took a while for any of the situation in which I found myself to start to make sense.
Alongside the multiple surgeries to reconstruct my left foot, the microbiologists were waging a parallel war against NDM-1 and they had very few weapons at their disposal.
Colistin, a highly toxic antibiotic, was used as the last-line of defence against the resistant gram-negative bacteria. Colistin damaged my kidneys to the extent that I required dialysis. 15 years later, my kidney function is deteriorating, possibly as a long-term consequence.”
Join our list of email supporters and you'll be the first to hear about our research updates, including details of our newly funded work for AMR
SubscribeColistin is a powerful, 'last-resort' antibiotic used to treat severe bacterial infections that cannot be cured by other medicines.
Because it can cause serious side effects, doctors usually save it for situations where a patient has a dangerous, drug-resistant infection and no other treatments are working.
”At the moment when I came closest to death, my sister asked my friends on Facebook to pray for me.
Meanwhile the microbiologists monitored me constantly, carefully titrating the last-resort antibiotic medication that saved my life. Either way, I pulled through.
Then, over the following year, I rapidly went blind with traumatic cataracts. Happily, I had surgery and I got my sight back."
"This experience was a stitch in a larger tapestry and, for me, a side effect of a profound initiation, an early chapter in an ongoing saga.
The microbiologists who got published thanks to saving my life thanked me profusely for my service to the study of hard-to-kill gram negative bacteria.
You’re welcome, humanity!"
Behind every health statistic is a person, a family and a life that could be changed.
Your support can help fund life-changing medical research into neglected health conditions – and bring us closer to a fairer, healthier future for every mind and every body.